# Loss of HuD Sensitizes Neuroblastoma Cells to Palmitate-Driven Stress-Induced Premature Senescence via PPARα Downregulation and FAO Impairment

**Authors:** Seungyeon Ryu, Jiyoon Seo, Ye Eun Sim, Se Hoon Jung, Wei Zhang, Seung Min Jeong, Eun Kyung Lee

PMC · DOI: 10.3390/cells15040316 · 2026-02-07

## TL;DR

This study shows how the protein HuD protects neuroblastoma cells from stress caused by excess fat by maintaining fatty acid oxidation and preventing premature aging.

## Contribution

The study identifies a new HuD–PPARα–FAO regulatory axis that prevents metabolic stress and senescence in neuroblastoma cells.

## Key findings

- HuD knockdown reduces fatty acid oxidation and increases lipid accumulation and ROS in response to palmitate.
- HuD binds to PPARα mRNA, protecting it from microRNA degradation and maintaining its expression.
- Loss of HuD leads to mitochondrial DNA release, IRF phosphorylation, and senescence marker upregulation.

## Abstract

Metabolic stress caused by lipid overload is a key driver of cellular dysfunction in aging and disease. Excess saturated fatty acids such as palmitate impair fatty acid oxidation (FAO), promote lipid accumulation, and increase reactive oxygen species (ROS), ultimately triggering premature senescence-like states. Senescence further amplifies vulnerability by worsening mitochondrial dysfunction, enhancing lipid imbalance, and sustaining pro-inflammatory signaling. Here, we investigated the role of the neuron-enriched RNA-binding protein HuD (ELAVL4) in protecting cells against lipotoxic stress. Using Neuro2a neuroblastoma cells, we found that HuD knockdown suppressed FAO, leading to increased lipid accumulation and elevated ROS following palmitate exposure. HuD-deficient cells also exhibited cytosolic mitochondrial DNA release, IRF phosphorylation, and upregulation of senescence markers. Mechanistically, RNA immunoprecipitation revealed that HuD binds directly to PPARα mRNA, sustaining its expression by competing with the PPARα-targeting microRNAs miR-9-5p and miR-22-3p. Loss of HuD reduced PPARα levels, thereby weakening the FAO capacity and sensitizing cells to palmitate-induced lipotoxic stress. These findings identify a previously unrecognized HuD–PPARα–FAO axis that restrains metabolic stress and senescence. By linking post-transcriptional regulation to lipid metabolism and inflammatory signaling, this work highlights stress-induced premature senescence as both an outcome and a propagator of metabolic dysfunction, providing insight into mechanisms of aging-related vulnerability.

## Linked entities

- **Genes:** ELAVL4 (ELAV like RNA binding protein 4) [NCBI Gene 1996], ELAVL4 (ELAV like RNA binding protein 4) [NCBI Gene 1996], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465]
- **Proteins:** ELAVL4 (ELAV like RNA binding protein 4), PPARA (peroxisome proliferator activated receptor alpha), TRIM63 (tripartite motif containing 63)
- **Chemicals:** palmitate (PubChem CID 985), fatty acids (PubChem CID 264)

## Full-text entities

- **Genes:** Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 25747] {aka PPAR}, Ppard (peroxisome proliferator activator receptor delta) [NCBI Gene 19015] {aka NUC-1, NUC1, Nr1c2, PPAR-beta, PPAR-delta, PPAR[b]}, ND4 (NADH dehydrogenase subunit 4) [NCBI Gene 17719], Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Cpt1b (carnitine palmitoyltransferase 1b, muscle) [NCBI Gene 12895] {aka Cpt1, Cpt1-m, Cpti, Cpti-m, M-cpti}, Mir223 (microRNA 223) [NCBI Gene 723814] {aka Mirn223, miR-223, mmu-mir-223}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, CYTB (cytochrome b) [NCBI Gene 17711], Tbk1 (TANK-binding kinase 1) [NCBI Gene 56480] {aka 1200008B05Rik}, Elavl4 (ELAV like RNA binding protein 4) [NCBI Gene 15572] {aka Elav, Hud, PNEM}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nsg1 (neuron specific gene family member 1) [NCBI Gene 18196] {aka Neep21, m234, p21}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Mir223 (microRNA 223) [NCBI Gene 100314060] {aka rno-mir-223}, Irf3 (interferon regulatory factor 3) [NCBI Gene 54131] {aka C920001K05Rik, IRF-3}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, Cgas (cyclic GMP-AMP synthase) [NCBI Gene 214763] {aka E330016A19Rik, Mb21d1}, Elavl4 (ELAV like RNA binding protein 4) [NCBI Gene 432358] {aka HuD}, Acadm (acyl-Coenzyme A dehydrogenase, medium chain) [NCBI Gene 11364] {aka MCAD}, Acads (acyl-Coenzyme A dehydrogenase, short chain) [NCBI Gene 11409] {aka Bcd-1, Bcd1, Hdlq8, SCAD}, Acadl (acyl-Coenzyme A dehydrogenase, long-chain) [NCBI Gene 11363] {aka LCAD}, Cpt2 (carnitine palmitoyltransferase 2) [NCBI Gene 12896] {aka CPTII}, Acsl1 (acyl-CoA synthetase long-chain family member 1) [NCBI Gene 14081] {aka Acas, Acas1, Acs, FACS, Facl2, LACS 1}
- **Diseases:** Neuroblastoma (MESH:D009447), metabolic dysfunction (MESH:D008659), neurologic (MESH:D009461), paraneoplastic anti-Hu (MESH:D010257), cancer (MESH:D009369), psychiatric conditions (MESH:D001523), Alzheimer's disease (MESH:D000544), schizophrenia (MESH:D012559), chronic inflammation (MESH:D007249), neurodegeneration (MESH:D019636), diseases (MESH:D004194), injury to (MESH:D014947), mitochondrial damage (MESH:D028361), Parkinson's disease (MESH:D010300), small-cell lung cancer (MESH:D055752), ALS (MESH:D008113), FAO (MESH:C536560), age (MESH:D019588), epilepsy (MESH:D004827), SIPS (MESH:D000079225), mitochondrial defects (MESH:C565376)
- **Chemicals:** SDS (MESH:D012967), Biotin (MESH:D001710), FCCP (MESH:D002259), NaOH (MESH:D012972), MitoSox  Red (MESH:C000597839), TRIzol (MESH:C411644), 2',7'-dichlorofluorescin diacetate (MESH:C029569), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (MESH:C108897), digitonin (MESH:D004072), etomoxir (MESH:C054207), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), Triton X-100 (MESH:D017830), TG (MESH:D014280), NaCl (MESH:D012965), fenofibrate (MESH:D011345), Oxygen (MESH:D010100), Nile Red (MESH:C044808), PVDF (MESH:C024865), ROS (MESH:D017382), MitoSox (MESH:C521281), DAPI (MESH:C007293), CO2 (MESH:D002245), rotenone (MESH:D012402), ATP (MESH:D000255), Lipid (MESH:D008055), paraformaldehyde (MESH:C003043), antimycin A (MESH:D000968), peroxide (MESH:D010545), Lipofectamine  2000 (MESH:C086724), Saturated fatty acids (MESH:D005227), X-gal (MESH:C044888), PA (MESH:D010168), H2O2 (MESH:D006861), oligomycin A (MESH:C031004), Cytiva (-), superoxide (MESH:D013481), HEPES (MESH:D006531), CTP (MESH:D003570), penicillin (MESH:D010406), JC-1 (MESH:C068624), doxorubicin (MESH:D004317)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** XFe24 — Mus musculus (Mouse), Hybridoma (CVCL_C5HY), -131 — Homo sapiens (Human), Transformed cell line (CVCL_7275), N2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939706/full.md

---
Source: https://tomesphere.com/paper/PMC12939706